nodes	percent_of_prediction	percent_of_DWPC	metapath
Melatonin—MTNR1A—type 2 diabetes mellitus	0.256	0.513	CbGaD
Melatonin—MTNR1B—type 2 diabetes mellitus	0.134	0.27	CbGaD
Melatonin—CALM1—type 2 diabetes mellitus	0.0823	0.165	CbGaD
Melatonin—CYP1A2—type 2 diabetes mellitus	0.0259	0.052	CbGaD
Melatonin—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0156	0.0667	CbGbCtD
Melatonin—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0153	0.0652	CbGbCtD
Melatonin—CYP2C9—Glipizide—type 2 diabetes mellitus	0.014	0.0596	CbGbCtD
Melatonin—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0133	0.0567	CbGbCtD
Melatonin—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0133	0.0567	CbGbCtD
Melatonin—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.013	0.0554	CbGbCtD
Melatonin—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0123	0.0523	CbGbCtD
Melatonin—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0118	0.0505	CbGbCtD
Melatonin—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0113	0.0483	CbGbCtD
Melatonin—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.011	0.0471	CbGbCtD
Melatonin—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.011	0.0471	CbGbCtD
Melatonin—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0102	0.0435	CbGbCtD
Melatonin—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00984	0.042	CbGbCtD
Melatonin—CYP2C9—Valsartan—type 2 diabetes mellitus	0.009	0.0384	CbGbCtD
Melatonin—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0089	0.038	CbGbCtD
Melatonin—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00842	0.0359	CbGbCtD
Melatonin—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00837	0.0357	CbGbCtD
Melatonin—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00802	0.0343	CbGbCtD
Melatonin—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0068	0.029	CbGbCtD
Melatonin—CYP2C19—Losartan—type 2 diabetes mellitus	0.00622	0.0265	CbGbCtD
Melatonin—CYP1A2—Losartan—type 2 diabetes mellitus	0.00574	0.0245	CbGbCtD
Melatonin—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00565	0.0241	CbGbCtD
Melatonin—CYP2C9—Losartan—type 2 diabetes mellitus	0.00517	0.0221	CbGbCtD
Melatonin—MT3—nerve—type 2 diabetes mellitus	0.00291	0.0686	CbGeAlD
Melatonin—MTNR1B—islet of Langerhans—type 2 diabetes mellitus	0.00213	0.0502	CbGeAlD
Melatonin—CALM1—sympathetic nervous system—type 2 diabetes mellitus	0.00185	0.0437	CbGeAlD
Melatonin—MTNR1B—retina—type 2 diabetes mellitus	0.00182	0.0429	CbGeAlD
Melatonin—ASMT—retina—type 2 diabetes mellitus	0.00177	0.0418	CbGeAlD
Melatonin—Agomelatine—MTNR1A—type 2 diabetes mellitus	0.00139	0.402	CrCbGaD
Melatonin—CALM1—autonomic nervous system—type 2 diabetes mellitus	0.00124	0.0294	CbGeAlD
Melatonin—CALR—islet of Langerhans—type 2 diabetes mellitus	0.00111	0.0262	CbGeAlD
Melatonin—MPO—artery—type 2 diabetes mellitus	0.001	0.0237	CbGeAlD
Melatonin—CALR—retina—type 2 diabetes mellitus	0.000949	0.0224	CbGeAlD
Melatonin—CALM2—peripheral nervous system—type 2 diabetes mellitus	0.000901	0.0213	CbGeAlD
Melatonin—CALM1—peripheral nervous system—type 2 diabetes mellitus	0.000897	0.0212	CbGeAlD
Melatonin—CALR—nephron tubule—type 2 diabetes mellitus	0.000894	0.0211	CbGeAlD
Melatonin—MPO—endothelium—type 2 diabetes mellitus	0.000847	0.02	CbGeAlD
Melatonin—CALR—cardiovascular system—type 2 diabetes mellitus	0.000803	0.019	CbGeAlD
Melatonin—CALR—kidney—type 2 diabetes mellitus	0.000786	0.0186	CbGeAlD
Melatonin—CALR—pancreas—type 2 diabetes mellitus	0.000781	0.0184	CbGeAlD
Melatonin—CALR—cortex of kidney—type 2 diabetes mellitus	0.000765	0.0181	CbGeAlD
Melatonin—Agomelatine—MTNR1B—type 2 diabetes mellitus	0.000732	0.211	CrCbGaD
Melatonin—CALR—adipose tissue—type 2 diabetes mellitus	0.000708	0.0167	CbGeAlD
Melatonin—CALM2—artery—type 2 diabetes mellitus	0.000708	0.0167	CbGeAlD
Melatonin—CALM1—artery—type 2 diabetes mellitus	0.000705	0.0166	CbGeAlD
Melatonin—CALM2—nerve—type 2 diabetes mellitus	0.000703	0.0166	CbGeAlD
Melatonin—CALM1—nerve—type 2 diabetes mellitus	0.000699	0.0165	CbGeAlD
Melatonin—NQO2—islet of Langerhans—type 2 diabetes mellitus	0.000626	0.0148	CbGeAlD
Melatonin—CALM2—endothelium—type 2 diabetes mellitus	0.000598	0.0141	CbGeAlD
Melatonin—CALM1—endothelium—type 2 diabetes mellitus	0.000595	0.0141	CbGeAlD
Melatonin—NQO2—nephron tubule—type 2 diabetes mellitus	0.000504	0.0119	CbGeAlD
Melatonin—CALR—liver—type 2 diabetes mellitus	0.000497	0.0117	CbGeAlD
Melatonin—NQO2—kidney—type 2 diabetes mellitus	0.000443	0.0105	CbGeAlD
Melatonin—NQO2—pancreas—type 2 diabetes mellitus	0.00044	0.0104	CbGeAlD
Melatonin—CALM3—islet of Langerhans—type 2 diabetes mellitus	0.000433	0.0102	CbGeAlD
Melatonin—NQO2—cortex of kidney—type 2 diabetes mellitus	0.000432	0.0102	CbGeAlD
Melatonin—NQO2—adipose tissue—type 2 diabetes mellitus	0.000399	0.00943	CbGeAlD
Melatonin—CALM3—retina—type 2 diabetes mellitus	0.00037	0.00875	CbGeAlD
Melatonin—CALM3—nephron tubule—type 2 diabetes mellitus	0.000349	0.00824	CbGeAlD
Melatonin—MPO—cardiovascular system—type 2 diabetes mellitus	0.000349	0.00823	CbGeAlD
Melatonin—MPO—kidney—type 2 diabetes mellitus	0.000341	0.00805	CbGeAlD
Melatonin—CALM2—islet of Langerhans—type 2 diabetes mellitus	0.00034	0.00803	CbGeAlD
Melatonin—MPO—pancreas—type 2 diabetes mellitus	0.000339	0.008	CbGeAlD
Melatonin—CALM1—islet of Langerhans—type 2 diabetes mellitus	0.000339	0.008	CbGeAlD
Melatonin—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.00031	0.00733	CbGeAlD
Melatonin—CALM3—pancreas—type 2 diabetes mellitus	0.000305	0.00719	CbGeAlD
Melatonin—CALM3—cortex of kidney—type 2 diabetes mellitus	0.000299	0.00705	CbGeAlD
Melatonin—CYP1B1—nephron tubule—type 2 diabetes mellitus	0.000297	0.007	CbGeAlD
Melatonin—CALM2—retina—type 2 diabetes mellitus	0.000291	0.00687	CbGeAlD
Melatonin—CALM1—retina—type 2 diabetes mellitus	0.00029	0.00684	CbGeAlD
Melatonin—NQO2—liver—type 2 diabetes mellitus	0.00028	0.00662	CbGeAlD
Melatonin—CALM3—adipose tissue—type 2 diabetes mellitus	0.000276	0.00652	CbGeAlD
Melatonin—CALM2—nephron tubule—type 2 diabetes mellitus	0.000274	0.00647	CbGeAlD
Melatonin—CALM1—nephron tubule—type 2 diabetes mellitus	0.000273	0.00644	CbGeAlD
Melatonin—SLC22A8—kidney—type 2 diabetes mellitus	0.000273	0.00644	CbGeAlD
Melatonin—CYP1B1—cardiovascular system—type 2 diabetes mellitus	0.000266	0.00629	CbGeAlD
Melatonin—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000266	0.00627	CbGeAlD
Melatonin—CYP1B1—kidney—type 2 diabetes mellitus	0.000261	0.00615	CbGeAlD
Melatonin—CYP1B1—cortex of kidney—type 2 diabetes mellitus	0.000254	0.00599	CbGeAlD
Melatonin—CYP19A1—adipose tissue—type 2 diabetes mellitus	0.000251	0.00593	CbGeAlD
Melatonin—ESR1—cardiovascular system—type 2 diabetes mellitus	0.000248	0.00585	CbGeAlD
Melatonin—CALM2—cardiovascular system—type 2 diabetes mellitus	0.000246	0.00581	CbGeAlD
Melatonin—CALM1—cardiovascular system—type 2 diabetes mellitus	0.000245	0.00578	CbGeAlD
Melatonin—ESR1—kidney—type 2 diabetes mellitus	0.000242	0.00572	CbGeAlD
Melatonin—CALM2—kidney—type 2 diabetes mellitus	0.000241	0.00569	CbGeAlD
Melatonin—CALM1—kidney—type 2 diabetes mellitus	0.00024	0.00566	CbGeAlD
Melatonin—CALM2—pancreas—type 2 diabetes mellitus	0.000239	0.00565	CbGeAlD
Melatonin—CALM1—pancreas—type 2 diabetes mellitus	0.000238	0.00562	CbGeAlD
Melatonin—CYP1B1—adipose tissue—type 2 diabetes mellitus	0.000235	0.00555	CbGeAlD
Melatonin—CALM2—cortex of kidney—type 2 diabetes mellitus	0.000235	0.00554	CbGeAlD
Melatonin—CALM1—cortex of kidney—type 2 diabetes mellitus	0.000233	0.00551	CbGeAlD
Melatonin—ESR1—adipose tissue—type 2 diabetes mellitus	0.000218	0.00516	CbGeAlD
Melatonin—CALM2—adipose tissue—type 2 diabetes mellitus	0.000217	0.00512	CbGeAlD
Melatonin—CALM1—adipose tissue—type 2 diabetes mellitus	0.000216	0.0051	CbGeAlD
Melatonin—MPO—liver—type 2 diabetes mellitus	0.000216	0.00509	CbGeAlD
Melatonin—Nabumetone—CYP1A2—type 2 diabetes mellitus	0.000207	0.0599	CrCbGaD
Melatonin—CALM3—liver—type 2 diabetes mellitus	0.000194	0.00458	CbGeAlD
Melatonin—Agomelatine—HTR2C—type 2 diabetes mellitus	0.000187	0.0539	CrCbGaD
Melatonin—CYP1A1—kidney—type 2 diabetes mellitus	0.000184	0.00435	CbGeAlD
Melatonin—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000181	0.00428	CbGeAlD
Melatonin—Rizatriptan—CYP1A2—type 2 diabetes mellitus	0.000176	0.0509	CrCbGaD
Melatonin—CYP19A1—liver—type 2 diabetes mellitus	0.000176	0.00416	CbGeAlD
Melatonin—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000166	0.00392	CbGeAlD
Melatonin—CYP1B1—liver—type 2 diabetes mellitus	0.000165	0.00389	CbGeAlD
Melatonin—Zolmitriptan—CYP1A2—type 2 diabetes mellitus	0.000161	0.0466	CrCbGaD
Melatonin—ESR1—liver—type 2 diabetes mellitus	0.000153	0.00362	CbGeAlD
Melatonin—CALM2—liver—type 2 diabetes mellitus	0.000152	0.00359	CbGeAlD
Melatonin—CALM1—liver—type 2 diabetes mellitus	0.000151	0.00358	CbGeAlD
Melatonin—CYP2C19—liver—type 2 diabetes mellitus	0.000145	0.00341	CbGeAlD
Melatonin—Agomelatine—CYP1A2—type 2 diabetes mellitus	0.000141	0.0407	CrCbGaD
Melatonin—Nabumetone—PTGS2—type 2 diabetes mellitus	0.000134	0.0388	CrCbGaD
Melatonin—Almotriptan—CYP2E1—type 2 diabetes mellitus	0.000129	0.0371	CrCbGaD
Melatonin—Almotriptan—CYP1A2—type 2 diabetes mellitus	0.000122	0.0353	CrCbGaD
Melatonin—CYP1A2—liver—type 2 diabetes mellitus	0.000118	0.00279	CbGeAlD
Melatonin—CYP1A1—liver—type 2 diabetes mellitus	0.000116	0.00275	CbGeAlD
Melatonin—CYP2C9—liver—type 2 diabetes mellitus	0.000112	0.00265	CbGeAlD
Melatonin—Anxiety—Orlistat—type 2 diabetes mellitus	8.31e-05	0.000716	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	8.29e-05	0.000714	CcSEcCtD
Melatonin—Nervousness—Irbesartan—type 2 diabetes mellitus	8.28e-05	0.000713	CcSEcCtD
Melatonin—Dry mouth—Valsartan—type 2 diabetes mellitus	8.26e-05	0.000711	CcSEcCtD
Melatonin—Muscle spasms—Irbesartan—type 2 diabetes mellitus	8.19e-05	0.000706	CcSEcCtD
Melatonin—Dry mouth—Orlistat—type 2 diabetes mellitus	8.16e-05	0.000703	CcSEcCtD
Melatonin—Vomiting—Glipizide—type 2 diabetes mellitus	8.11e-05	0.000698	CcSEcCtD
Melatonin—Syncope—Metformin—type 2 diabetes mellitus	8.1e-05	0.000698	CcSEcCtD
Melatonin—Almotriptan—CYP3A4—type 2 diabetes mellitus	8.09e-05	0.0234	CrCbGaD
Melatonin—Dizziness—Pioglitazone—type 2 diabetes mellitus	8.08e-05	0.000696	CcSEcCtD
Melatonin—Infection—Valsartan—type 2 diabetes mellitus	8.04e-05	0.000693	CcSEcCtD
Melatonin—Rash—Glipizide—type 2 diabetes mellitus	8.04e-05	0.000692	CcSEcCtD
Melatonin—Vision blurred—Irbesartan—type 2 diabetes mellitus	8.03e-05	0.000692	CcSEcCtD
Melatonin—Dermatitis—Glipizide—type 2 diabetes mellitus	8.03e-05	0.000692	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	8.03e-05	0.000691	CcSEcCtD
Melatonin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	8.02e-05	0.000691	CcSEcCtD
Melatonin—Erythema—Losartan—type 2 diabetes mellitus	8.02e-05	0.000691	CcSEcCtD
Melatonin—Headache—Glipizide—type 2 diabetes mellitus	7.99e-05	0.000688	CcSEcCtD
Melatonin—Palpitations—Metformin—type 2 diabetes mellitus	7.98e-05	0.000687	CcSEcCtD
Melatonin—Insomnia—Gliclazide—type 2 diabetes mellitus	7.97e-05	0.000686	CcSEcCtD
Melatonin—Shock—Valsartan—type 2 diabetes mellitus	7.96e-05	0.000686	CcSEcCtD
Melatonin—Infection—Orlistat—type 2 diabetes mellitus	7.95e-05	0.000684	CcSEcCtD
Melatonin—Loss of consciousness—Metformin—type 2 diabetes mellitus	7.94e-05	0.000684	CcSEcCtD
Melatonin—Nervous system disorder—Valsartan—type 2 diabetes mellitus	7.94e-05	0.000684	CcSEcCtD
Melatonin—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	7.92e-05	0.000683	CcSEcCtD
Melatonin—Paraesthesia—Gliclazide—type 2 diabetes mellitus	7.91e-05	0.000681	CcSEcCtD
Melatonin—Flatulence—Losartan—type 2 diabetes mellitus	7.9e-05	0.000681	CcSEcCtD
Melatonin—Tension—Losartan—type 2 diabetes mellitus	7.87e-05	0.000678	CcSEcCtD
Melatonin—Dizziness—Glimepiride—type 2 diabetes mellitus	7.87e-05	0.000678	CcSEcCtD
Melatonin—Skin disorder—Valsartan—type 2 diabetes mellitus	7.86e-05	0.000677	CcSEcCtD
Melatonin—Nervous system disorder—Orlistat—type 2 diabetes mellitus	7.84e-05	0.000676	CcSEcCtD
Melatonin—Dizziness—Sitagliptin—type 2 diabetes mellitus	7.84e-05	0.000675	CcSEcCtD
Melatonin—Agitation—Irbesartan—type 2 diabetes mellitus	7.83e-05	0.000675	CcSEcCtD
Melatonin—Somnolence—Gliclazide—type 2 diabetes mellitus	7.83e-05	0.000675	CcSEcCtD
Melatonin—Hypertension—Metformin—type 2 diabetes mellitus	7.8e-05	0.000672	CcSEcCtD
Melatonin—Nervousness—Losartan—type 2 diabetes mellitus	7.79e-05	0.000671	CcSEcCtD
Melatonin—Angioedema—Irbesartan—type 2 diabetes mellitus	7.79e-05	0.000671	CcSEcCtD
Melatonin—Skin disorder—Orlistat—type 2 diabetes mellitus	7.77e-05	0.000669	CcSEcCtD
Melatonin—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	7.76e-05	0.000669	CcSEcCtD
Melatonin—Back pain—Losartan—type 2 diabetes mellitus	7.76e-05	0.000668	CcSEcCtD
Melatonin—Abdominal pain—Glyburide—type 2 diabetes mellitus	7.76e-05	0.000668	CcSEcCtD
Melatonin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	7.75e-05	0.000668	CcSEcCtD
Melatonin—Muscle spasms—Losartan—type 2 diabetes mellitus	7.71e-05	0.000664	CcSEcCtD
Melatonin—Asthenia—Bromocriptine—type 2 diabetes mellitus	7.7e-05	0.000663	CcSEcCtD
Melatonin—Chest pain—Metformin—type 2 diabetes mellitus	7.69e-05	0.000662	CcSEcCtD
Melatonin—Vertigo—Irbesartan—type 2 diabetes mellitus	7.66e-05	0.00066	CcSEcCtD
Melatonin—Headache—Pioglitazone—type 2 diabetes mellitus	7.65e-05	0.000659	CcSEcCtD
Melatonin—Syncope—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000658	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	7.64e-05	0.000658	CcSEcCtD
Melatonin—Leukopenia—Irbesartan—type 2 diabetes mellitus	7.63e-05	0.000657	CcSEcCtD
Melatonin—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	7.61e-05	0.000655	CcSEcCtD
Melatonin—Fatigue—Gliclazide—type 2 diabetes mellitus	7.6e-05	0.000654	CcSEcCtD
Melatonin—Nausea—Glipizide—type 2 diabetes mellitus	7.57e-05	0.000652	CcSEcCtD
Melatonin—Vomiting—Glimepiride—type 2 diabetes mellitus	7.56e-05	0.000651	CcSEcCtD
Melatonin—Vision blurred—Losartan—type 2 diabetes mellitus	7.56e-05	0.000651	CcSEcCtD
Melatonin—Vomiting—Sitagliptin—type 2 diabetes mellitus	7.54e-05	0.000649	CcSEcCtD
Melatonin—Pain—Gliclazide—type 2 diabetes mellitus	7.53e-05	0.000649	CcSEcCtD
Melatonin—Rash—Glimepiride—type 2 diabetes mellitus	7.5e-05	0.000646	CcSEcCtD
Melatonin—Dermatitis—Glimepiride—type 2 diabetes mellitus	7.49e-05	0.000645	CcSEcCtD
Melatonin—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	7.49e-05	0.000645	CcSEcCtD
Melatonin—Rash—Sitagliptin—type 2 diabetes mellitus	7.48e-05	0.000644	CcSEcCtD
Melatonin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	7.47e-05	0.000643	CcSEcCtD
Melatonin—Headache—Glimepiride—type 2 diabetes mellitus	7.45e-05	0.000642	CcSEcCtD
Melatonin—Headache—Sitagliptin—type 2 diabetes mellitus	7.43e-05	0.00064	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	7.37e-05	0.000635	CcSEcCtD
Melatonin—Agitation—Losartan—type 2 diabetes mellitus	7.37e-05	0.000635	CcSEcCtD
Melatonin—Hypertension—Irbesartan—type 2 diabetes mellitus	7.36e-05	0.000634	CcSEcCtD
Melatonin—Angioedema—Losartan—type 2 diabetes mellitus	7.33e-05	0.000631	CcSEcCtD
Melatonin—Infection—Metformin—type 2 diabetes mellitus	7.32e-05	0.000631	CcSEcCtD
Melatonin—Insomnia—Valsartan—type 2 diabetes mellitus	7.32e-05	0.000631	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.29e-05	0.000628	CcSEcCtD
Melatonin—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.27e-05	0.000626	CcSEcCtD
Melatonin—Chest pain—Irbesartan—type 2 diabetes mellitus	7.26e-05	0.000625	CcSEcCtD
Melatonin—Arthralgia—Irbesartan—type 2 diabetes mellitus	7.26e-05	0.000625	CcSEcCtD
Melatonin—Shock—Metformin—type 2 diabetes mellitus	7.25e-05	0.000625	CcSEcCtD
Melatonin—Insomnia—Orlistat—type 2 diabetes mellitus	7.23e-05	0.000623	CcSEcCtD
Melatonin—Anxiety—Irbesartan—type 2 diabetes mellitus	7.23e-05	0.000623	CcSEcCtD
Melatonin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.23e-05	0.000623	CcSEcCtD
Melatonin—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.23e-05	0.000623	CcSEcCtD
Melatonin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.22e-05	0.000622	CcSEcCtD
Melatonin—Vertigo—Losartan—type 2 diabetes mellitus	7.21e-05	0.000621	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.000621	CcSEcCtD
Melatonin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.2e-05	0.00062	CcSEcCtD
Melatonin—Somnolence—Valsartan—type 2 diabetes mellitus	7.2e-05	0.00062	CcSEcCtD
Melatonin—Syncope—Losartan—type 2 diabetes mellitus	7.19e-05	0.00062	CcSEcCtD
Melatonin—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.18e-05	0.000619	CcSEcCtD
Melatonin—Leukopenia—Losartan—type 2 diabetes mellitus	7.18e-05	0.000618	CcSEcCtD
Melatonin—Skin disorder—Metformin—type 2 diabetes mellitus	7.16e-05	0.000617	CcSEcCtD
Melatonin—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000615	CcSEcCtD
Melatonin—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.12e-05	0.000614	CcSEcCtD
Melatonin—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.1e-05	0.000611	CcSEcCtD
Melatonin—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.1e-05	0.000611	CcSEcCtD
Melatonin—Palpitations—Losartan—type 2 diabetes mellitus	7.09e-05	0.000611	CcSEcCtD
Melatonin—Nausea—Glimepiride—type 2 diabetes mellitus	7.07e-05	0.000609	CcSEcCtD
Melatonin—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.05e-05	0.000607	CcSEcCtD
Melatonin—Nausea—Sitagliptin—type 2 diabetes mellitus	7.04e-05	0.000607	CcSEcCtD
Melatonin—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.04e-05	0.000606	CcSEcCtD
Melatonin—Asthenia—Glyburide—type 2 diabetes mellitus	7.04e-05	0.000606	CcSEcCtD
Melatonin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.99e-05	0.000602	CcSEcCtD
Melatonin—Fatigue—Valsartan—type 2 diabetes mellitus	6.98e-05	0.000601	CcSEcCtD
Melatonin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.96e-05	0.0006	CcSEcCtD
Melatonin—Pruritus—Glyburide—type 2 diabetes mellitus	6.94e-05	0.000598	CcSEcCtD
Melatonin—Mental disorder—Ramipril—type 2 diabetes mellitus	6.92e-05	0.000596	CcSEcCtD
Melatonin—Infection—Irbesartan—type 2 diabetes mellitus	6.91e-05	0.000595	CcSEcCtD
Melatonin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.9e-05	0.000595	CcSEcCtD
Melatonin—Fatigue—Orlistat—type 2 diabetes mellitus	6.9e-05	0.000594	CcSEcCtD
Melatonin—Erythema—Ramipril—type 2 diabetes mellitus	6.88e-05	0.000592	CcSEcCtD
Melatonin—Malnutrition—Ramipril—type 2 diabetes mellitus	6.88e-05	0.000592	CcSEcCtD
Melatonin—Shock—Irbesartan—type 2 diabetes mellitus	6.84e-05	0.000589	CcSEcCtD
Melatonin—Pain—Orlistat—type 2 diabetes mellitus	6.84e-05	0.000589	CcSEcCtD
Melatonin—Arthralgia—Losartan—type 2 diabetes mellitus	6.83e-05	0.000588	CcSEcCtD
Melatonin—Chest pain—Losartan—type 2 diabetes mellitus	6.83e-05	0.000588	CcSEcCtD
Melatonin—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.82e-05	0.000588	CcSEcCtD
Melatonin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	6.82e-05	0.000588	CcSEcCtD
Melatonin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	6.81e-05	0.000587	CcSEcCtD
Melatonin—Anxiety—Losartan—type 2 diabetes mellitus	6.8e-05	0.000586	CcSEcCtD
Melatonin—Rash—Bromocriptine—type 2 diabetes mellitus	6.77e-05	0.000583	CcSEcCtD
Melatonin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.76e-05	0.000582	CcSEcCtD
Melatonin—Skin disorder—Irbesartan—type 2 diabetes mellitus	6.76e-05	0.000582	CcSEcCtD
Melatonin—Tension—Ramipril—type 2 diabetes mellitus	6.75e-05	0.000581	CcSEcCtD
Melatonin—Headache—Bromocriptine—type 2 diabetes mellitus	6.72e-05	0.000579	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.72e-05	0.000578	CcSEcCtD
Melatonin—Nervousness—Ramipril—type 2 diabetes mellitus	6.68e-05	0.000575	CcSEcCtD
Melatonin—Dry mouth—Losartan—type 2 diabetes mellitus	6.68e-05	0.000575	CcSEcCtD
Melatonin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.62e-05	0.00057	CcSEcCtD
Melatonin—Paraesthesia—Metformin—type 2 diabetes mellitus	6.62e-05	0.00057	CcSEcCtD
Melatonin—Muscle spasms—Ramipril—type 2 diabetes mellitus	6.61e-05	0.00057	CcSEcCtD
Melatonin—Somnolence—Metformin—type 2 diabetes mellitus	6.55e-05	0.000564	CcSEcCtD
Melatonin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.54e-05	0.000563	CcSEcCtD
Melatonin—Infection—Losartan—type 2 diabetes mellitus	6.5e-05	0.00056	CcSEcCtD
Melatonin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.49e-05	0.000559	CcSEcCtD
Melatonin—Dyspepsia—Metformin—type 2 diabetes mellitus	6.49e-05	0.000559	CcSEcCtD
Melatonin—Shock—Losartan—type 2 diabetes mellitus	6.44e-05	0.000555	CcSEcCtD
Melatonin—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.42e-05	0.000553	CcSEcCtD
Melatonin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.41e-05	0.000552	CcSEcCtD
Melatonin—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.4e-05	0.000551	CcSEcCtD
Melatonin—Nausea—Bromocriptine—type 2 diabetes mellitus	6.37e-05	0.000549	CcSEcCtD
Melatonin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.36e-05	0.000548	CcSEcCtD
Melatonin—Fatigue—Metformin—type 2 diabetes mellitus	6.35e-05	0.000547	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.34e-05	0.000546	CcSEcCtD
Melatonin—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.32e-05	0.000545	CcSEcCtD
Melatonin—Asthenia—Gliclazide—type 2 diabetes mellitus	6.32e-05	0.000544	CcSEcCtD
Melatonin—Agitation—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000544	CcSEcCtD
Melatonin—Angioedema—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000541	CcSEcCtD
Melatonin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000538	CcSEcCtD
Melatonin—Vomiting—Glyburide—type 2 diabetes mellitus	6.24e-05	0.000537	CcSEcCtD
Melatonin—Pruritus—Gliclazide—type 2 diabetes mellitus	6.23e-05	0.000537	CcSEcCtD
Melatonin—Rash—Glyburide—type 2 diabetes mellitus	6.19e-05	0.000533	CcSEcCtD
Melatonin—Somnolence—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000533	CcSEcCtD
Melatonin—Dermatitis—Glyburide—type 2 diabetes mellitus	6.18e-05	0.000532	CcSEcCtD
Melatonin—Vertigo—Ramipril—type 2 diabetes mellitus	6.18e-05	0.000532	CcSEcCtD
Melatonin—Syncope—Ramipril—type 2 diabetes mellitus	6.17e-05	0.000531	CcSEcCtD
Melatonin—Leukopenia—Ramipril—type 2 diabetes mellitus	6.16e-05	0.00053	CcSEcCtD
Melatonin—Headache—Glyburide—type 2 diabetes mellitus	6.15e-05	0.000529	CcSEcCtD
Melatonin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.12e-05	0.000527	CcSEcCtD
Melatonin—Palpitations—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000523	CcSEcCtD
Melatonin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.04e-05	0.000521	CcSEcCtD
Melatonin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.03e-05	0.000519	CcSEcCtD
Melatonin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.01e-05	0.000517	CcSEcCtD
Melatonin—Fatigue—Irbesartan—type 2 diabetes mellitus	6e-05	0.000517	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.96e-05	0.000514	CcSEcCtD
Melatonin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.96e-05	0.000514	CcSEcCtD
Melatonin—Pain—Irbesartan—type 2 diabetes mellitus	5.95e-05	0.000512	CcSEcCtD
Melatonin—Insomnia—Losartan—type 2 diabetes mellitus	5.92e-05	0.00051	CcSEcCtD
Melatonin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.89e-05	0.000508	CcSEcCtD
Melatonin—Paraesthesia—Losartan—type 2 diabetes mellitus	5.88e-05	0.000506	CcSEcCtD
Melatonin—Arthralgia—Ramipril—type 2 diabetes mellitus	5.86e-05	0.000504	CcSEcCtD
Melatonin—Chest pain—Ramipril—type 2 diabetes mellitus	5.86e-05	0.000504	CcSEcCtD
Melatonin—Anxiety—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000503	CcSEcCtD
Melatonin—Nausea—Glyburide—type 2 diabetes mellitus	5.83e-05	0.000502	CcSEcCtD
Melatonin—Abdominal pain—Metformin—type 2 diabetes mellitus	5.83e-05	0.000502	CcSEcCtD
Melatonin—Dizziness—Gliclazide—type 2 diabetes mellitus	5.83e-05	0.000502	CcSEcCtD
Melatonin—Somnolence—Losartan—type 2 diabetes mellitus	5.82e-05	0.000501	CcSEcCtD
Melatonin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.81e-05	0.000501	CcSEcCtD
Melatonin—Asthenia—Valsartan—type 2 diabetes mellitus	5.81e-05	0.0005	CcSEcCtD
Melatonin—Dyspepsia—Losartan—type 2 diabetes mellitus	5.76e-05	0.000496	CcSEcCtD
Melatonin—Asthenia—Orlistat—type 2 diabetes mellitus	5.74e-05	0.000494	CcSEcCtD
Melatonin—Pruritus—Valsartan—type 2 diabetes mellitus	5.73e-05	0.000493	CcSEcCtD
Melatonin—Dry mouth—Ramipril—type 2 diabetes mellitus	5.73e-05	0.000493	CcSEcCtD
Melatonin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.69e-05	0.00049	CcSEcCtD
Melatonin—Pruritus—Orlistat—type 2 diabetes mellitus	5.66e-05	0.000487	CcSEcCtD
Melatonin—Fatigue—Losartan—type 2 diabetes mellitus	5.64e-05	0.000486	CcSEcCtD
Melatonin—Vomiting—Gliclazide—type 2 diabetes mellitus	5.6e-05	0.000482	CcSEcCtD
Melatonin—Pain—Losartan—type 2 diabetes mellitus	5.6e-05	0.000482	CcSEcCtD
Melatonin—Rash—Gliclazide—type 2 diabetes mellitus	5.55e-05	0.000478	CcSEcCtD
Melatonin—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.55e-05	0.000478	CcSEcCtD
Melatonin—Shock—Ramipril—type 2 diabetes mellitus	5.52e-05	0.000476	CcSEcCtD
Melatonin—Headache—Gliclazide—type 2 diabetes mellitus	5.52e-05	0.000475	CcSEcCtD
Melatonin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.5e-05	0.000474	CcSEcCtD
Melatonin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.5e-05	0.000474	CcSEcCtD
Melatonin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.5e-05	0.000473	CcSEcCtD
Melatonin—Skin disorder—Ramipril—type 2 diabetes mellitus	5.45e-05	0.00047	CcSEcCtD
Melatonin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.35e-05	0.000461	CcSEcCtD
Melatonin—Dizziness—Valsartan—type 2 diabetes mellitus	5.35e-05	0.000461	CcSEcCtD
Melatonin—Dizziness—Orlistat—type 2 diabetes mellitus	5.29e-05	0.000456	CcSEcCtD
Melatonin—Asthenia—Metformin—type 2 diabetes mellitus	5.29e-05	0.000455	CcSEcCtD
Melatonin—Nausea—Gliclazide—type 2 diabetes mellitus	5.23e-05	0.000451	CcSEcCtD
Melatonin—Pruritus—Metformin—type 2 diabetes mellitus	5.21e-05	0.000449	CcSEcCtD
Melatonin—Abdominal pain—Losartan—type 2 diabetes mellitus	5.17e-05	0.000446	CcSEcCtD
Melatonin—Vomiting—Valsartan—type 2 diabetes mellitus	5.15e-05	0.000443	CcSEcCtD
Melatonin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.12e-05	0.000441	CcSEcCtD
Melatonin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.11e-05	0.00044	CcSEcCtD
Melatonin—Rash—Valsartan—type 2 diabetes mellitus	5.1e-05	0.00044	CcSEcCtD
Melatonin—Dermatitis—Valsartan—type 2 diabetes mellitus	5.1e-05	0.000439	CcSEcCtD
Melatonin—Vomiting—Orlistat—type 2 diabetes mellitus	5.09e-05	0.000438	CcSEcCtD
Melatonin—Insomnia—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000437	CcSEcCtD
Melatonin—Headache—Valsartan—type 2 diabetes mellitus	5.07e-05	0.000437	CcSEcCtD
Melatonin—Rash—Orlistat—type 2 diabetes mellitus	5.04e-05	0.000434	CcSEcCtD
Melatonin—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000434	CcSEcCtD
Melatonin—Dermatitis—Orlistat—type 2 diabetes mellitus	5.04e-05	0.000434	CcSEcCtD
Melatonin—Headache—Orlistat—type 2 diabetes mellitus	5.01e-05	0.000432	CcSEcCtD
Melatonin—Asthenia—Irbesartan—type 2 diabetes mellitus	4.99e-05	0.00043	CcSEcCtD
Melatonin—Somnolence—Ramipril—type 2 diabetes mellitus	4.99e-05	0.00043	CcSEcCtD
Melatonin—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000426	CcSEcCtD
Melatonin—Pruritus—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.000424	CcSEcCtD
Melatonin—Dizziness—Metformin—type 2 diabetes mellitus	4.87e-05	0.00042	CcSEcCtD
Melatonin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000417	CcSEcCtD
Melatonin—Fatigue—Ramipril—type 2 diabetes mellitus	4.84e-05	0.000417	CcSEcCtD
Melatonin—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.82e-05	0.000415	CcSEcCtD
Melatonin—Nausea—Valsartan—type 2 diabetes mellitus	4.81e-05	0.000414	CcSEcCtD
Melatonin—Nausea—Orlistat—type 2 diabetes mellitus	4.75e-05	0.000409	CcSEcCtD
Melatonin—Asthenia—Losartan—type 2 diabetes mellitus	4.7e-05	0.000405	CcSEcCtD
Melatonin—Vomiting—Metformin—type 2 diabetes mellitus	4.69e-05	0.000404	CcSEcCtD
Melatonin—Rash—Metformin—type 2 diabetes mellitus	4.65e-05	0.0004	CcSEcCtD
Melatonin—Dermatitis—Metformin—type 2 diabetes mellitus	4.64e-05	0.0004	CcSEcCtD
Melatonin—Pruritus—Losartan—type 2 diabetes mellitus	4.63e-05	0.000399	CcSEcCtD
Melatonin—Headache—Metformin—type 2 diabetes mellitus	4.62e-05	0.000398	CcSEcCtD
Melatonin—Dizziness—Irbesartan—type 2 diabetes mellitus	4.6e-05	0.000396	CcSEcCtD
Melatonin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.59e-05	0.000395	CcSEcCtD
Melatonin—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.44e-05	0.000382	CcSEcCtD
Melatonin—Vomiting—Irbesartan—type 2 diabetes mellitus	4.42e-05	0.000381	CcSEcCtD
Melatonin—Rash—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.000378	CcSEcCtD
Melatonin—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.38e-05	0.000377	CcSEcCtD
Melatonin—Nausea—Metformin—type 2 diabetes mellitus	4.38e-05	0.000377	CcSEcCtD
Melatonin—Headache—Irbesartan—type 2 diabetes mellitus	4.36e-05	0.000375	CcSEcCtD
Melatonin—Dizziness—Losartan—type 2 diabetes mellitus	4.33e-05	0.000373	CcSEcCtD
Melatonin—Vomiting—Losartan—type 2 diabetes mellitus	4.16e-05	0.000358	CcSEcCtD
Melatonin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000356	CcSEcCtD
Melatonin—Nausea—Irbesartan—type 2 diabetes mellitus	4.13e-05	0.000356	CcSEcCtD
Melatonin—Rash—Losartan—type 2 diabetes mellitus	4.13e-05	0.000356	CcSEcCtD
Melatonin—Dermatitis—Losartan—type 2 diabetes mellitus	4.12e-05	0.000355	CcSEcCtD
Melatonin—Headache—Losartan—type 2 diabetes mellitus	4.1e-05	0.000353	CcSEcCtD
Melatonin—Asthenia—Ramipril—type 2 diabetes mellitus	4.03e-05	0.000347	CcSEcCtD
Melatonin—Pruritus—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000342	CcSEcCtD
Melatonin—Nausea—Losartan—type 2 diabetes mellitus	3.89e-05	0.000335	CcSEcCtD
Melatonin—Dizziness—Ramipril—type 2 diabetes mellitus	3.71e-05	0.00032	CcSEcCtD
Melatonin—Vomiting—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000307	CcSEcCtD
Melatonin—Rash—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000305	CcSEcCtD
Melatonin—Dermatitis—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000305	CcSEcCtD
Melatonin—Headache—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000303	CcSEcCtD
Melatonin—Nausea—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000287	CcSEcCtD
Melatonin—CALM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.13e-06	1.07e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	1.13e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—BCL2—type 2 diabetes mellitus	1.12e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—BCL2—type 2 diabetes mellitus	1.12e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—C3—type 2 diabetes mellitus	1.12e-06	1.06e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.12e-06	1.06e-05	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.12e-06	1.06e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—NOS3—type 2 diabetes mellitus	1.11e-06	1.05e-05	CbGpPWpGaD
Melatonin—CALM3—Disease—PIK3R1—type 2 diabetes mellitus	1.11e-06	1.05e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.11e-06	1.05e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.11e-06	1.05e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	1.1e-06	1.04e-05	CbGpPWpGaD
Melatonin—CALM2—Immune System—RELA—type 2 diabetes mellitus	1.1e-06	1.04e-05	CbGpPWpGaD
Melatonin—CALM1—Immune System—RELA—type 2 diabetes mellitus	1.1e-06	1.04e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	1.1e-06	1.04e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PPARG—type 2 diabetes mellitus	1.09e-06	1.03e-05	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—C3—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—C3—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—NOS3—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—PIK3R1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM2—Disease—NOS3—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Melatonin—CALM1—Disease—PIK3R1—type 2 diabetes mellitus	1.08e-06	1.02e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	1.07e-06	1.01e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.07e-06	1.01e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.06e-06	1.01e-05	CbGpPWpGaD
Melatonin—CALM3—Metabolism—INS—type 2 diabetes mellitus	1.06e-06	1.01e-05	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AGT—type 2 diabetes mellitus	1.06e-06	1.01e-05	CbGpPWpGaD
Melatonin—CALM3—Hemostasis—AKT1—type 2 diabetes mellitus	1.06e-06	1e-05	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	1.05e-06	9.95e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.05e-06	9.95e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PPARG—type 2 diabetes mellitus	1.05e-06	9.93e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PPARG—type 2 diabetes mellitus	1.05e-06	9.93e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.05e-06	9.89e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—LEP—type 2 diabetes mellitus	1.04e-06	9.85e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—APOE—type 2 diabetes mellitus	1.04e-06	9.85e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	1.04e-06	9.83e-06	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—IL6—type 2 diabetes mellitus	1.03e-06	9.77e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.03e-06	9.76e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.03e-06	9.76e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	1.03e-06	9.74e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.03e-06	9.74e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.03e-06	9.74e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.03e-06	9.74e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	1.03e-06	9.74e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—INS—type 2 diabetes mellitus	1.03e-06	9.74e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—INS—type 2 diabetes mellitus	1.03e-06	9.74e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.03e-06	9.73e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.03e-06	9.73e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	1.03e-06	9.71e-06	CbGpPWpGaD
Melatonin—CALM2—Hemostasis—AKT1—type 2 diabetes mellitus	1.02e-06	9.68e-06	CbGpPWpGaD
Melatonin—CALM1—Hemostasis—AKT1—type 2 diabetes mellitus	1.02e-06	9.68e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.02e-06	9.64e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—PTGS2—type 2 diabetes mellitus	1.02e-06	9.64e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.01e-06	9.56e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	1.01e-06	9.55e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.01e-06	9.53e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.01e-06	9.53e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.01e-06	9.53e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.01e-06	9.53e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	1e-06	9.45e-06	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—IL6—type 2 diabetes mellitus	9.99e-07	9.45e-06	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—IL6—type 2 diabetes mellitus	9.99e-07	9.45e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.96e-07	9.42e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.96e-07	9.42e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	9.88e-07	9.34e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.88e-07	9.34e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	9.87e-07	9.34e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	9.87e-07	9.34e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—PTGS2—type 2 diabetes mellitus	9.86e-07	9.32e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—PTGS2—type 2 diabetes mellitus	9.86e-07	9.32e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	9.83e-07	9.3e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.82e-07	9.29e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—ALB—type 2 diabetes mellitus	9.76e-07	9.23e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	9.71e-07	9.18e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	9.7e-07	9.17e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	9.67e-07	9.15e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—NFKB1—type 2 diabetes mellitus	9.58e-07	9.06e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	9.56e-07	9.04e-06	CbGpPWpGaD
Melatonin—CALM3—Innate Immune System—AKT1—type 2 diabetes mellitus	9.53e-07	9.01e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.5e-07	8.99e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.5e-07	8.99e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.49e-07	8.98e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	9.47e-07	8.96e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—ALB—type 2 diabetes mellitus	9.44e-07	8.93e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—ALB—type 2 diabetes mellitus	9.44e-07	8.93e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	9.42e-07	8.91e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PIK3R1—type 2 diabetes mellitus	9.33e-07	8.83e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—NOS3—type 2 diabetes mellitus	9.33e-07	8.83e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	9.3e-07	8.79e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	9.29e-07	8.79e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—NFKB1—type 2 diabetes mellitus	9.27e-07	8.77e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—NFKB1—type 2 diabetes mellitus	9.27e-07	8.77e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	9.26e-07	8.76e-06	CbGpPWpGaD
Melatonin—CALM2—Innate Immune System—AKT1—type 2 diabetes mellitus	9.22e-07	8.71e-06	CbGpPWpGaD
Melatonin—CALM1—Innate Immune System—AKT1—type 2 diabetes mellitus	9.22e-07	8.71e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	9.16e-07	8.66e-06	CbGpPWpGaD
Melatonin—CALM3—Adaptive Immune System—AKT1—type 2 diabetes mellitus	9.15e-07	8.65e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—NOS3—type 2 diabetes mellitus	9.03e-07	8.54e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—NOS3—type 2 diabetes mellitus	9.03e-07	8.54e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PIK3R1—type 2 diabetes mellitus	9.03e-07	8.54e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.03e-07	8.54e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	9e-07	8.51e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	8.99e-07	8.5e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.99e-07	8.5e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.99e-07	8.5e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.97e-07	8.48e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—SRC—type 2 diabetes mellitus	8.93e-07	8.44e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—INS—type 2 diabetes mellitus	8.9e-07	8.42e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.87e-07	8.39e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	8.86e-07	8.37e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	8.86e-07	8.37e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	8.85e-07	8.37e-06	CbGpPWpGaD
Melatonin—CALM2—Adaptive Immune System—AKT1—type 2 diabetes mellitus	8.85e-07	8.37e-06	CbGpPWpGaD
Melatonin—CALM1—Adaptive Immune System—AKT1—type 2 diabetes mellitus	8.85e-07	8.37e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	8.82e-07	8.34e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	8.8e-07	8.32e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	8.77e-07	8.3e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.76e-07	8.28e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	8.72e-07	8.25e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—SRC—type 2 diabetes mellitus	8.64e-07	8.17e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—SRC—type 2 diabetes mellitus	8.64e-07	8.17e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—INS—type 2 diabetes mellitus	8.61e-07	8.14e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—INS—type 2 diabetes mellitus	8.61e-07	8.14e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.61e-07	8.14e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.6e-07	8.13e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.57e-07	8.1e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	8.54e-07	8.08e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—PTGS2—type 2 diabetes mellitus	8.54e-07	8.07e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.47e-07	8.01e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.47e-07	8.01e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	8.44e-07	7.98e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	8.43e-07	7.97e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.33e-07	7.87e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.33e-07	7.87e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.32e-07	7.87e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.32e-07	7.87e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.29e-07	7.84e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.29e-07	7.84e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—SRC—type 2 diabetes mellitus	8.27e-07	7.82e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	8.26e-07	7.81e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—PTGS2—type 2 diabetes mellitus	8.26e-07	7.81e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—PTGS2—type 2 diabetes mellitus	8.26e-07	7.81e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—SRC—type 2 diabetes mellitus	8.24e-07	7.8e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.17e-07	7.73e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	8.1e-07	7.66e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	8.1e-07	7.66e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.05e-07	7.62e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—SRC—type 2 diabetes mellitus	7.97e-07	7.54e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—SRC—type 2 diabetes mellitus	7.97e-07	7.54e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	7.94e-07	7.51e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.91e-07	7.48e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.91e-07	7.48e-06	CbGpPWpGaD
Melatonin—ESR1—Gene Expression—AKT1—type 2 diabetes mellitus	7.9e-07	7.47e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—EGFR—type 2 diabetes mellitus	7.83e-07	7.4e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.8e-07	7.38e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.8e-07	7.38e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	7.69e-07	7.27e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	7.68e-07	7.27e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	7.58e-07	7.16e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—EGFR—type 2 diabetes mellitus	7.57e-07	7.16e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—EGFR—type 2 diabetes mellitus	7.57e-07	7.16e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	7.56e-07	7.15e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.55e-07	7.14e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.55e-07	7.14e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.55e-07	7.14e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.55e-07	7.14e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	7.54e-07	7.13e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	7.54e-07	7.13e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	7.45e-07	7.05e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.39e-07	6.99e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—TGFB1—type 2 diabetes mellitus	7.37e-07	6.97e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—RELA—type 2 diabetes mellitus	7.35e-07	6.95e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.25e-07	6.85e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	7.25e-07	6.85e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	7.25e-07	6.85e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—EGFR—type 2 diabetes mellitus	7.23e-07	6.83e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—TGFB1—type 2 diabetes mellitus	7.13e-07	6.74e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—TGFB1—type 2 diabetes mellitus	7.13e-07	6.74e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—RELA—type 2 diabetes mellitus	7.11e-07	6.72e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—RELA—type 2 diabetes mellitus	7.11e-07	6.72e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—EGFR—type 2 diabetes mellitus	6.99e-07	6.61e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—EGFR—type 2 diabetes mellitus	6.99e-07	6.61e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	6.91e-07	6.53e-06	CbGpPWpGaD
Melatonin—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	6.86e-07	6.49e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	6.63e-07	6.27e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.63e-07	6.27e-06	CbGpPWpGaD
Melatonin—CYP1B1—Metabolism—AKT1—type 2 diabetes mellitus	6.61e-07	6.25e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	6.61e-07	6.25e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	6.61e-07	6.25e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.58e-07	6.23e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	6.57e-07	6.21e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	6.44e-07	6.09e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.41e-07	6.06e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.41e-07	6.06e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.37e-07	6.02e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.37e-07	6.02e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.26e-07	5.92e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.2e-07	5.86e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.07e-07	5.74e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.06e-07	5.73e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.06e-07	5.73e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	6.04e-07	5.72e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—IL6—type 2 diabetes mellitus	6.01e-07	5.69e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.99e-07	5.67e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.99e-07	5.67e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	5.9e-07	5.58e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.87e-07	5.56e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.87e-07	5.56e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—IL6—type 2 diabetes mellitus	5.82e-07	5.5e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—IL6—type 2 diabetes mellitus	5.82e-07	5.5e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—SRC—type 2 diabetes mellitus	5.77e-07	5.46e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	5.65e-07	5.34e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	5.65e-07	5.34e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.62e-07	5.32e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.58e-07	5.28e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—SRC—type 2 diabetes mellitus	5.58e-07	5.28e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.57e-07	5.27e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—IL6—type 2 diabetes mellitus	5.55e-07	5.25e-06	CbGpPWpGaD
Melatonin—CALM3—Immune System—AKT1—type 2 diabetes mellitus	5.55e-07	5.25e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.44e-07	5.14e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.44e-07	5.14e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—IL6—type 2 diabetes mellitus	5.37e-07	5.08e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—IL6—type 2 diabetes mellitus	5.37e-07	5.08e-06	CbGpPWpGaD
Melatonin—CALM2—Immune System—AKT1—type 2 diabetes mellitus	5.37e-07	5.08e-06	CbGpPWpGaD
Melatonin—CALM1—Immune System—AKT1—type 2 diabetes mellitus	5.37e-07	5.08e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	5.16e-07	4.88e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.16e-07	4.88e-06	CbGpPWpGaD
Melatonin—ESR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.14e-07	4.86e-06	CbGpPWpGaD
Melatonin—CALM3—Disease—AKT1—type 2 diabetes mellitus	5.12e-07	4.84e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.06e-07	4.78e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.99e-07	4.72e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.99e-07	4.72e-06	CbGpPWpGaD
Melatonin—CALM1—Disease—AKT1—type 2 diabetes mellitus	4.96e-07	4.69e-06	CbGpPWpGaD
Melatonin—CALM2—Disease—AKT1—type 2 diabetes mellitus	4.96e-07	4.69e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.89e-07	4.63e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.89e-07	4.63e-06	CbGpPWpGaD
Melatonin—CALM3—Metabolism—AKT1—type 2 diabetes mellitus	4.29e-07	4.06e-06	CbGpPWpGaD
Melatonin—CALM2—Metabolism—AKT1—type 2 diabetes mellitus	4.15e-07	3.92e-06	CbGpPWpGaD
Melatonin—CALM1—Metabolism—AKT1—type 2 diabetes mellitus	4.15e-07	3.92e-06	CbGpPWpGaD
Melatonin—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	4.07e-07	3.85e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—IL6—type 2 diabetes mellitus	3.89e-07	3.68e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.76e-07	3.56e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.76e-07	3.56e-06	CbGpPWpGaD
Melatonin—CALM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.59e-07	3.39e-06	CbGpPWpGaD
Melatonin—CALM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.47e-07	3.28e-06	CbGpPWpGaD
Melatonin—CALM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.47e-07	3.28e-06	CbGpPWpGaD
Melatonin—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	3.33e-07	3.15e-06	CbGpPWpGaD
Melatonin—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	3.04e-07	2.87e-06	CbGpPWpGaD
Melatonin—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	2.6e-07	2.45e-06	CbGpPWpGaD
